ArticleActa dermato-venereologica2025

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation.

Chih-Tsung Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.